A Drug to Drug Interaction Study of Sotagliflozin With Hydrochlorothiazide

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 3, 2018

Primary Completion Date

March 2, 2018

Study Completion Date

March 2, 2018

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Sotagliflozin (SAR439954)

"Pharmaceutical form: Tablet~Route of administration: Oral"

DRUG

Hydrochlorothiazide

"Pharmaceutical form: Tablet~Route of administration: Oral"

Trial Locations (1)

75247

Investigational Site Number 8400001, Dallas

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT03387657 - A Drug to Drug Interaction Study of Sotagliflozin With Hydrochlorothiazide | Biotech Hunter | Biotech Hunter